Biogen to cut 1,000 jobs to save costs as Alzheimer’s drug launch gathers pace, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Investors have pinned their hopes on Leqembi as the U.S drugmaker’s money spinner multiple sclerosis and spinal muscular atrophy (SMA) treatments face fierce competition from cheaper versions and rival drugs., Investors have pinned their hopes on Leqembi as the U.S drugmaker’s money spinner multiple sclerosis and spinal muscular atrophy (SMA) treatments face fierce competition from cheaper versions and rival drugs., , Read More